How should I manage a patient with low iron and low folate levels but a normal complete blood count?

Management of Low Iron with Normal Folate and Normal CBC

Start oral iron supplementation immediately—even with a normal CBC, low iron stores require treatment to prevent progression to anemia and to address iron-deficiency symptoms. 1

Diagnostic Confirmation

Your patient has iron deficiency without anemia, a condition that warrants treatment despite the normal complete blood count. The key diagnostic parameters are:

• Serum ferritin < 30 ng/mL confirms absolute iron deficiency in the absence of inflammation 2
• Transferrin saturation < 20% indicates depleted iron stores 2
• Normal hemoglobin does not exclude the need for iron therapy, as iron deficiency causes symptoms (fatigue, reduced exercise tolerance, impaired cognition) before anemia develops 1

The British Society of Gastroenterology explicitly notes that "the need for investigation of patients with iron deficiency but no anaemia has not been assessed in clinical studies," but this does not negate the physiological requirement for iron repletion 2.

Immediate Treatment Protocol

First-Line Oral Iron Therapy

Initiate ferrous sulfate 200 mg (≈65 mg elemental iron) once daily immediately, without waiting for further diagnostic workup 1. This regimen is:

• The most cost-effective oral formulation with proven efficacy 1
• Superior to multiple daily doses because hepcidin remains elevated for ~48 hours after each dose, blocking subsequent absorption and increasing gastrointestinal side effects 1
• Best taken on an empty stomach; if intolerance occurs, may be taken with food 1

Add vitamin C 500 mg with each iron dose to markedly enhance absorption, especially when transferrin saturation is low 1. Avoid tea and coffee within 1 hour of the iron dose, as these inhibit absorption 1.

If ferrous sulfate is not tolerated, ferrous fumarate (≈106 mg elemental iron) or ferrous gluconate (≈38 mg elemental iron) provide comparable efficacy 1.

Treatment Duration and Monitoring

• Continue oral iron for 3 months after iron stores normalize (ferritin ≥30 ng/mL), resulting in a total treatment duration of roughly 4–6 months 1
• Recheck ferritin and transferrin saturation at 4 weeks to confirm response; ferritin should begin rising 1
• Monitor ferritin every 3 months during the first year, then annually 1

Investigation of Underlying Cause

The normal folate level eliminates one potential cause, but you must still identify why iron stores are depleted:

For Adult Men and Postmenopausal Women

Perform bidirectional endoscopy (upper endoscopy + colonoscopy) to exclude gastrointestinal malignancy, as iron deficiency may be the sole presenting sign 2, 1. The British Society of Gastroenterology emphasizes that "asymptomatic colonic and gastric carcinoma may present with IDA and exclusion of these conditions is of prime concern" 2.

For Premenopausal Women

Follow this algorithmic approach 1:

1. Assess menstrual blood loss first—menorrhagia, pregnancy, and breastfeeding account for 5–10% of iron deficiency in menstruating women 1
2. Screen for celiac disease with tissue transglutaminase IgA antibodies (present in 3–5% of iron-deficiency cases) 1
3. Test for Helicobacter pylori infection 1
4. Reserve endoscopy for women ≥50 years, those with gastrointestinal symptoms, alarm features, or strong family history of colorectal cancer 1

Additional Considerations

• Dietary assessment: Identify iron-deficient diets, though borderline deficiency is common and should not preclude full investigation 2
• Medication review: Document NSAID use, aspirin, and proton-pump inhibitors, all of which contribute to iron depletion 2
• Previous surgery: Gastrectomy, gastric bypass, or other GI resections impair iron absorption 2

When to Switch to Intravenous Iron

Even without anemia, IV iron is indicated when 1:

• Intolerance to ≥2 different oral iron formulations (ferrous sulfate, fumarate, or gluconate)
• Ferritin fails to improve after 4 weeks of compliant oral therapy
• Active inflammatory bowel disease (inflammation-driven hepcidin blocks oral absorption)
• Post-bariatric surgery (disrupted duodenal absorption)
• Celiac disease with inadequate response despite strict gluten-free diet adherence

Preferred IV formulations that replenish iron in 1–2 infusions 1:

• Ferric carboxymaltose: 750–1000 mg per 15-minute infusion; two doses ≥7 days apart
• Ferric derisomaltose: 1000 mg as a single infusion

Avoid iron dextran as first-line due to higher anaphylaxis risk (≈0.6–0.7%) 1. All IV iron must be administered in a setting equipped for emergency resuscitation 1.

Critical Pitfalls to Avoid

• Do not wait for anemia to develop before treating iron deficiency; iron-deficiency symptoms warrant treatment even with normal hemoglobin 1
• Do not prescribe multiple daily oral doses; this increases side effects without improving efficacy due to hepcidin-mediated absorption blockade 1
• Do not stop iron therapy when ferritin normalizes; continue for an additional 3 months to fully replenish stores 1
• Do not overlook vitamin C supplementation when oral iron response is suboptimal 1
• Do not delay investigation of the underlying cause while providing supplementation; gastrointestinal malignancy may present solely with iron deficiency 1
• Do not assume dietary insufficiency is the sole cause in adult men or postmenopausal women without completing endoscopic evaluation 2

Special Considerations

Folate Status

Your patient's normal folate level is reassuring and requires no supplementation. However, be aware that:

• Combined iron and folate deficiency can mask microcytosis through a raised red cell distribution width (RDW) 2
• Some research suggests iron therapy alone may increase serum folate and vitamin B12 levels in iron-deficient individuals, though the mechanism remains unclear 3
• Folate supplementation during iron therapy does not impair iron absorption and may be beneficial in specific populations (pregnancy, malabsorption syndromes) 4

Monitoring for Treatment Failure

If iron stores do not improve after 4 weeks of compliant oral therapy 1:

1. Verify adherence to the once-daily regimen
2. Evaluate for ongoing blood loss (repeat endoscopy or video-capsule endoscopy)
3. Consider malabsorption syndromes (celiac disease, inflammatory bowel disease)
4. Check for concurrent vitamin B12 deficiency (can coexist with iron deficiency)
5. Reassess for systemic disease or bone-marrow pathology
6. Transition to intravenous iron if oral therapy failure is confirmed

Long-Term Follow-Up

After successful iron repletion 1:

• Monitor ferritin every 3 months for the first year, then annually
• Reinitiate iron supplementation if ferritin falls below 30 ng/mL
• Reassess the underlying cause if iron deficiency recurs despite treatment